Peijia Medical Overview
- Year Founded
-
2013
![Year Founded](/img/profile-preview/icons/flag.png)
- Status
-
Public
- Employees
-
1,050
![Employees](/img/profile-preview/icons/employee-count.png)
- Stock Symbol
-
09996
![Stock Symbol](/img/profile-preview/icons/stock-arrow.png)
- Investments
-
3
- Share Price
-
$0.48
- (As of Wednesday Closing)
Peijia Medical General Information
Description
Peijia Medical Ltd is focused on the interventional procedural, transcatheter valve therapeutic, and the neurointerventional procedural medical device market in China. The company's product candidates include Transcatheter Aortic Valve Replacement products, Transcatheter Mitral Valve Replacement/Transcatheter Tricuspid Valve Replacement products, Ancillary products, Neurointerventional products, and its product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates. Its operating segments are Transcatheter Valve Therapeutic Business and Neurointerventional Business.
Contact Information
Website
www.peijiamedical.comCorporate Office
- No.8, Zhongtian Lane, Suzhou Industrial park
- Suzhou, Jiangsu
- China
Corporate Office
- No.8, Zhongtian Lane, Suzhou Industrial park
- Suzhou, Jiangsu
- China
Peijia Medical Stock Performance
As of 15-Jan-2025, Peijia Medical’s stock price is $0.48. Its current market cap is $316M with 665M shares.
(As of Wednesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.48 | $0.48 | $0.28 - $0.83 | $316M | 665M | 378K | -$0.05 |
Peijia Medical Financials Summary
As of 30-Jun-2024, Peijia Medical has a trailing 12-month revenue of $71.9M.
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 92,243 | 516,937 | 552,642 | 664,859 |
Revenue | 71,905 | 62,351 | 37,246 | 21,145 |
EBITDA | (39,218) | (54,836) | (60,366) | (88,479) |
Net Income | (34,981) | (55,482) | (60,555) | (88,928) |
Total Assets | 359,640 | 376,938 | 480,697 | 496,332 |
Total Debt | 34,767 | 31,196 | 19,114 | 1,197 |
Peijia Medical Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Peijia Medical Comparisons
Industry
Financing
Details
Peijia Medical Competitors (1)
One of Peijia Medical’s competitors is Venus Medtech, a Formerly VC-backed company based in Hangzhou, China.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Venus Medtech | Formerly VC-backed | Hangzhou, China |
Peijia Medical Patents
Peijia Medical Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230389947-A1 | Electrode assembly and shock wave apparatus using the electrode assembly | Pending | 05-Feb-2021 | ||
EP-4289372-A1 | Electrode assembly and shock wave apparatus using same | Pending | 05-Feb-2021 | ||
JP-2024501577-A | System for clamping tissue | Pending | 30-Dec-2020 | ||
JP-2024501722-A | Fixation device for clamping tissue | Active | 30-Dec-2020 | ||
US-20240197478-A1 | Fixing device for clamping tissue | Pending | 30-Dec-2020 | A61F2/2463 |
Peijia Medical Signals
Peijia Medical Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Peijia Medical Investments & Acquisitions (3)
Peijia Medical’s most recent deal was a PE Growth/Expansion with JenaValve Technology for . The deal was made on 31-Aug-2022.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
JenaValve Technology | 31-Aug-2022 | PE Growth/Expansion | Therapeutic Devices | ||
inQB8 TTVR Technology | 09-Jun-2021 | Corporate Asset Purchase | Buildings and Property | ||
Achieva Medical | 01-Jan-2019 | Merger/Acquisition | Other Devices and Supplies |
Peijia Medical ESG
Risk Overview
Risk Rating
Updated April, 21, 2023
30.38 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,104
Rank
Percentile
![](/img/profile-preview/esg/type-3/covered-companies.png)
Healthcare
Industry
of 588
Rank
Percentile
![](/img/profile-preview/esg/type-3/industry.png)
Medical Devices
Subindustry
of 200
Rank
Percentile
![](/img/profile-preview/esg/type-3/subindustry.png)
Affiliates
Subsidiaries (1)
Name | Industry | Location | Year Founded |
---|---|---|---|
Achieva Medical | Shanghai, China | 2003 |
Peijia Medical FAQs
-
When was Peijia Medical founded?
Peijia Medical was founded in 2013.
-
Where is Peijia Medical headquartered?
Peijia Medical is headquartered in Suzhou, China.
-
What is the size of Peijia Medical?
Peijia Medical has 1,050 total employees.
-
What industry is Peijia Medical in?
Peijia Medical’s primary industry is Therapeutic Devices.
-
Is Peijia Medical a private or public company?
Peijia Medical is a Public company.
-
What is Peijia Medical’s stock symbol?
The ticker symbol for Peijia Medical is 09996.
-
What is the current stock price of Peijia Medical?
As of 15-Jan-2025 the stock price of Peijia Medical is $0.48.
-
What is the current market cap of Peijia Medical?
The current market capitalization of Peijia Medical is $316M.
-
What is Peijia Medical’s current revenue?
The trailing twelve month revenue for Peijia Medical is $71.9M.
-
Who are Peijia Medical’s competitors?
Venus Medtech is a competitor of Peijia Medical.
-
What is Peijia Medical’s annual earnings per share (EPS)?
Peijia Medical’s EPS for 12 months was -$0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »